日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

乳腺癌中EGFR/PI3K/PTEN/Akt/mTORC1通路失调:治疗干预的可能性

Davis, Nicole M; Sokolosky, Melissa; Stadelman, Kristin; Abrams, Steve L; Libra, Massimo; Candido, Saverio; Nicoletti, Ferdinando; Polesel, Jerry; Maestro, Roberta; D'Assoro, Antonino; Drobot, Lyudmyla; Rakus, Dariusz; Gizak, Agnieszka; Laidler, Piotr; Dulińska-Litewka, Joanna; Basecke, Joerg; Mijatovic, Sanja; Maksimovic-Ivanic, Danijela; Montalto, Giuseppe; Cervello, Melchiorre; Fitzgerald, Timothy L; Demidenko, Zoya; Martelli, Alberto M; Cocco, Lucio; Steelman, Linda S; McCubrey, James A

Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells

Akt和mTOR参与乳腺癌细胞的化疗和激素耐药性以及对放射线的反应

Steelman, Linda S; Navolanic, Patrick; Chappell, William H; Abrams, Stephen L; Wong, Ellis W T; Martelli, Alberto M; Cocco, Lucio; Stivala, Franca; Libra, Massimo; Nicoletti, Ferdinando; Drobot, Lyudmyla B; Franklin, Richard A; McCubrey, James A

CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes.

CIN85/RukL 是肾素和足细胞蛋白的新型结合伴侣,介导足细胞裂隙膜的更新

Tossidou Irini, Teng Beina, Drobot Lyudmyla, Meyer-Schwesinger Catherine, Worthmann Kirstin, Haller Hermann, Schiffer Mario